Cynvenio and ATGen Open Recruitment for New LiquidBiopsy Clinical Research Study in Triple Negative Breast Cancer

LOS ANGELES–(BUSINESS WIRE)–Cynvenio and ATGen have begun recruitment for a clinical trial to study Triple Negative Breast Cancer using LiquidBiopsy technology.
Source: BusinessWire-Primary
{inline_image}